Undervalued to begin with, shows efficacy, cap raise extra cash, 'deals on table'. Possible fda partial approval late next year.. Same could happen here.
Undervalued to begin with, shows efficacy, cap raise extra cash,...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $117.2M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 13.0¢ | $168.5K | 1.260M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 633259 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 874939 | 7 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |